Substance Use Disorders in Adolescents: IAP Guidelines
Written By : Ayesha Sadaf
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-12-05 13:45 GMT | Update On 2022-12-05 13:45 GMT
Advertisement
Substance use in adolescence can have widespread negative effects on adolescent health, including school failure, respiratory disease, high-risk sexual behaviors, injury,after 35 weeks of gestation and even death. Although some view the occasional use of substances such as alcohol or marijuana as part of normal adolescent development, there exists significant potential for injury even with occasional use. Adolescents with substance use problems present in a variety of ways:
Intoxicated in the emergency department
In your clinic with physical complaints, e.g., persistent abdominal pain, palpitations, chest pain, recurrent sore throat, and persistent nasal discharge.
Brought in by parents for behavioral concerns, changes in school performance, sudden mood swings, stealing, or lying.
No presenting signs or symptoms; disclosed only on direct questioning by healthcare professionals.
The Indian Academy of Pediatrics (IAP) has released Standard Treatment Guidelines 2022 for Substance Use Disorders in Adolescents. The lead author for these guidelines on Substance Use Disorders in Adolescents is Dr. TP Jayaraman along with co-author Dr. Yatesh Pujar and Dr. Kamlesh Parekh. The guidelines come Under the Auspices of the IAP Action Plan 2022, and the members of the IAP Standard Treatment Guidelines Committee include Chairperson Remesh Kumar R, IAP Coordinator Vineet Saxena, National Coordinators SS Kamath, Vinod H Ratageri, Member Secretaries Krishna Mohan R, Vishnu Mohan PT and Members Santanu Deb, Surender Singh Bisht, Prashant Kariya, Narmada Ashok, Pawan Kalyan.
Following are the major recommendations of guidelines:
Management of Substance Use In Adolescents:
General Management
Intoxicated adolescents should be assessed and managed through the ABCDE approach. Early resuscitation is a life-saving measure in intoxicated patients. A—Maintain Airway and give Antidotes, B—Facilitate Breathing, C—Circulation, D—Manage Disability, and E—Avoid Exposure to dangers.
Management of Specific Substances (Over and above Symptomatic Therapy)
Find out drug-specific indicators during history taking and physical examination:
• Amnesia: Barbiturates, ketamine, and flunitrazepam
• Gastritis, blackouts, and body odor: Alcohol
• Flu-like symptoms: Cocaine, inhalants, and marijuana
• Red conjunctiva and abnormal pupils: Marijuana
• Paint stains on face and clothes: Inhalants
• Chest pain and tachycardia: Cocaine and amphetamine
• Bronchospasm and constipation: Opiates and marijuana
• Increased appetite for sweets: Marijuana
• Altered body odor: Alcohol and inhalants
• Gynecomastia, small testes, and irregular periods: Marijuana
• Gasoline cans in car: Inhalants
Specific management:
• Alcohol: Intravenous (IV) fluids with glucose and vitamins
• Cannabis: Rarely serious and may not require anything else than the symptomatic treatment including benzodiazepines
• Opioids: IV naloxone-bolus 1–2 mg followed by infusion at 0.1 mg/kg/hour, maximum up to 10 mg total
• Stimulants: Benzodiazepines, aggressive cooling, and sodium bicarbonate for cocaine
• Benzodiazepine: Flumazenil can be used in severe intoxication associated with respiratory and neurological depression.
In Nonemergency Settings:
Management of substance use in adolescents needs team work from multiple specialties. Pediatricians are the ones who should screen them and guide them during routine office visits. HEEADSSS method of psychosocial assessment should be done in all adolescents visiting pediatric office to screen for substance use disorder (SUD). Look for red flag signs, i.e., headache, sore throat, worsening asthma, chronic cough, chest pain, gastritis, hepatitis, needle puncture marks, and pancreatitis.
Long-term Pharmacological Treatment of Substance Use Disorder:
Alcohol: Disulfiram (inhibits an enzyme involved in the metabolism of alcohol, causing an unpleasant reaction if alcohol is consumed after taking the medication), naltrexone (decreases alcohol-induced euphoria), acamprosate (reduces withdrawal symptoms), ondansetron, selective serotonin reuptake inhibitor (SSRI), topiramate, and baclofen.
Opioid: Replacement therapy: buprenorphine-naloxone and methadone (all act by both activating and blocking opioid receptors in the brain.
Cannabis: N-acetylcysteine and baclofen
Inhalants: Baclofen
Nicotine: Bupropion (reduces nicotine cravings and withdrawal symptoms and depression), varenicline (reduces nicotine cravings and withdrawal symptoms by stimulating nicotine receptors in the brain), nicotine replacement therapies: activate nicotine receptors in the brain, available in the form of a patch, gum, lozenge, nasal spray, and inhaler. CRAFFT questionnaire should be used to assist Screening to Brief Intervention (S2BI) method to screen adolescents for SUD
CRAFFT Screening Questionnaire :
C: Have you ever ridden in a Car driven by someone who was high or had been using drugs?
R: Do you ever use drugs to Relax or feel better or to fit in?
A: Do you ever use drugs when you are Alone?
F: Do you ever Forget things when you are on drugs?
F: Do your Family/Friends ask you to cut down on drugs?
T: Have you ever gotten into Trouble while using drugs?
MILD/Moderate Substance Use Disorder:
Outpatient department (OPD) treatment:
• Motivational intervention
• Express empathy and listening, bringing out positives in life and that the drugs as stumbling blocks toward reaching the goals
• Enhancing self-efficacy to resist drug use and rolling with resistance
• Request to sign a contract of life.
Manage any comorbidity, e.g., specific learning disability (SLD) and depression. Adolescent may require substance-specific counseling, e.g., for marijuana. OPD treatment on an individual basis or in a group format to be delivered during a visit lasting 3 hours, once or twice a week.
Severe Substance Use Disorder:
Pediatrician should refer such cases to multidisciplinary center/an adolescent-friendly psychiatrist for cognitive behavior therapy, motivational intervention, family therapy, and pharmacotherapy. These adolescents either require OPD treatment of 4–6 hours a day, 5 days a week while living at home, or may benefit from residential treatment—24-hour structured environment of a resource-intense high level of care. There are two approaches for managing these adolescents.
Behavioral Approaches:
Adolescent community reinforcement approach (A-CRA): Achieve and maintain abstinence from drugs by replacing influences in their lives that had reinforced substance use.
Cognitive behavioral therapy (CBT): A core element of CBT is teaching participants how to anticipate problems and helping them develop effective coping strategies. In CBT, adolescents explore the positive and negative consequences of using drugs. They learn to monitor their feelings and thoughts and recognize distorted thinking patterns and cues that trigger their substance abuse; identify and anticipate highrisk situations; and apply an array of self-control skills, including emotional regulation and anger management, practical problem solving, and substance refusal.
Contingency management (CM): Provides adolescents an opportunity to earn low-cost incentives such as prizes or cash vouchers.
Motivational enhancement therapy (MET): Motivational interviewing sessions in which a therapist helps the patient develop a desire to participate in treatment by providing nonconfrontational feedback and helps adolescents resolve their ambivalence about engaging in treatment and quitting their drug use.
Twelve-step facilitation therapy: As in Alcoholics Anonymous (AA) or Narcotics Anonymous (NA) stress the participant's acceptance that life has become unmanageable, that abstinence from drug use is needed, and that willpower alone cannot overcome the problem.
Family-based Approaches:
Brief strategic family therapy (BSFT): Over the course of 12–16 sessions, the BSFT counselor establishes a relationship with each family member, observes how the members behave with one another, and assists the family in changing negative interaction patterns.
Family behavior therapy (FBT): The adolescent and at least one parent participate in treatment planning and choose specific interventions from a menu of evidence-based treatment options. Therapists encourage family members to use behavioral strategies taught in sessions and apply their new skills to improve the home environment.
Multidimensional family therapy (MDFT): A comprehensive family- and community-based treatment useful for substance-abusing adolescents with behavior problems such as conduct disorder and delinquency.
Functional family therapy (FFT): Combines a family systems view of family functioning (which asserts that unhealthy family interactions underlie problem behaviors) with behavioral techniques to improve communication, problemsolving, conflict resolution, and parenting skills.
Multisystemic therapy (MST): MST is a comprehensive and intensive familyand community-based treatment for severe cases.
Recovery Support Services:These include mutual help groups, e.g., AA and NA, peer recovery support services, assertive continuing care (ACC), recovery high schools, etc. Support systems are mandatory for recovery to be sustained and free of relapse.
Reference:
- Indian academy of pediatrics. Mission Kishore Uday Manual 2018-19. Mumbai, India: Indian academy of pediatrics; 2019.
- Kliegman RM, St. Geme J. Adolescent substance abuse. In: Kliegman RM, St. Geme J (Eds). Nelson Textbook of Pediatrics, 21st edition. Philadelphia, PA: Saunders Elsevier; 2019.
- National Institute on Drug Abuse. (2011). Preventing Drug Use among Children and Adolescents (In Brief). [online] Available from: https://nida.nih.gov/publications/preventing-drug-use-amongchildren-adolescents/prevention-principles. [Last accessed August, 2022].
- Sathanantham S, Dayasiri K, Thadchanamoorthy V. Approach to the adolescent with substance use in the acute setting. Cureus. 2021;13(7):e16309.
The guidelines can be accessed on the official site of IAP: https://iapindia.org/standard-treatment-guidelines/
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.